Reckitt Benckiser appeals Nurofen loss

Competition & Consumer Protection 2018-03-05 11:44 am By Cat Fredenburgh | Melbourne

Please login to bookmark

Reckitt Benckiser has filed an appeal against GlaxoSmithKline, after a judge found the consumer goods giant misled consumers with claims that Nurofen was a more effective pain killer than its rival’s Panadol and ordered it to pay all of GlaxoSmithKline’s legal bill.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au